Study sheds light on emerging bacterial cause of urinary tract infections

 

New research from the University of South Alabama is shedding light on an emerging bacterial cause of urinary tract infections (UTIs) that appears to be more common along the Gulf Coast than previously recognized.

In a study published in the American Society for Microbiology's journal mSphere, researchers found that Pseudomonas aeruginosa accounted for approximately 4% of local UTI cases, nearly double the national average. The team also identified previously unknown genetic strains of the bacteria and concerning patterns of antibiotic resistance

The study, "Emerging pathogens in urinary tract infections: virulence and phenotypic characterization of Pseudomonas aeruginosa strains," was led by Allyson Shea, Ph.D., an assistant professor of microbiology and immunology at the Frederick P. Whiddon College of Medicine, with Rachel Fleck, an incoming first-year medical student, serving as first author.

Although most UTIs are caused by Escherichia coli (E. coli), Shea said P. aeruginosa has received comparatively little attention in urinary tract research.

"Pseudomonas aeruginosa is relatively understudied in the UTI field compared to pathogens like E. coli," Shea said. "Most of what we know about Pseudomonas virulence comes from lung and wound infection models, but the urinary tract is a very different environment. Our goal was to better define the genomic and phenotypic characteristics of urinary isolates specifically."

The research team analyzed 55 bacterial samples collected from patients with UTIs, examining how the bacteria differ genetically, how they cause disease, and how they respond to antibiotics.

Among the study's most significant findings was the discovery of numerous previously unidentified genetic strains.

"It suggests there is still substantial uncharacterized diversity among urinary P. aeruginosa isolates," Shea said. "Many of the strains circulating in our local patient population did not match previously described sequence types, which highlights how little we still know about P. aeruginosa in the urinary tract."

Researchers also found links between certain bacterial strains and specific patient populations. One strain appeared more frequently in patients with urinary catheters, while another was associated with diabetes.

The study further identified patterns of antibiotic resistance. Nearly one-third of the bacterial isolates were resistant to levofloxacin, a commonly prescribed antibiotic, and several strains were resistant to multiple antibiotics, making infections more difficult to treat.

While the higher regional prevalence raises important questions, Shea emphasized that researchers do not yet know why the bacteria appears more common along the Gulf Coast.

"Our study identified a higher prevalence of P. aeruginosa UTIs in our regional healthcare system compared to published national estimates, but we do not yet know why," she said. "It is likely multifactorial. Factors such as climate, patient population, healthcare-associated exposures and underlying comorbidities may all contribute, but larger epidemiologic studies would be needed to determine that."

Although the findings are not expected to change patient care immediately, Shea said they establish an important foundation for future research.

"There are no immediate implications for patient care from this study, but we hope this work helps highlight the genomic and phenotypic diversity of P. aeruginosa strains causing UTIs," she said. "Defining that diversity is an important first step toward understanding how these infections develop and persist in the urinary tract."

Source:
Journal reference:

Fleck, R. C., et al. (2026). Emerging pathogens in urinary tract infections: virulence and phenotypic characterization of Pseudomonas aeruginosa strains. mSphere. DOI: 10.1128/msphere.00151-26. https://journals.asm.org/doi/10.1128/msphere.00151-26

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New project targets recurrent urinary tract infections using phages